LEADER 02832nam  2200625Ia 450 
001 9910826813403321
005 20230607213828.0
010   $a0-309-18322-7
010   $a0-309-55787-9
010   $a0-309-52869-0
035   $a(CKB)111069351122158
035   $a(EBL)3375528
035   $a(SSID)ssj0000176889
035   $a(PQKBManifestationID)11182232
035   $a(PQKBTitleCode)TC0000176889
035   $a(PQKBWorkID)10210717
035   $a(PQKB)10743711
035   $a(MiAaPQ)EBC3375528
035   $a(Au-PeEL)EBL3375528
035   $a(CaPaEBR)ebr10038809
035   $a(OCoLC)923256971
035   $a(EXLCZ)99111069351122158
100   $a20020226d2001      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunization safety review$b[electronic resource] $emeasles-mumps-rubella vaccine and autism /$fKathleen Stratton ... [et al.], editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$dc2001
215   $a1 online resource (102 p.)
225 1 $aCompass series
300   $aDescription based upon print version of record.
311   $a0-309-07447-9 
320   $aIncludes bibliographical references (p. 60-69).
327   $a""Front Matter""; ""REVIEWERS""; ""Foreword""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism""; ""ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT""; ""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR ASSESSING CAUSALITY""; ""UNDER REVIEW: THE MMRa???AUTISM HYPOTHESIS""; ""PLAUSIBILITY ASSESSMENT""; ""CAUSALITY ARGUMENT""; ""RECOMMENDATIONS""; ""SUMMARY""; ""REFERENCES""; ""APPENDIX A January 11, 2001 Meeting Agenda""; ""APPENDIX B March 8, 2001 Meeting Agenda""
327   $a""APPENDIX C Immunization Safety Review Committee Biosketches""""APPENDIX D Research Needs and Opportunities Related to the Measles-Mumps-Rubella Vaccine and Autism""
410  0$aCompass series.
606   $aVaccination$xComplications
606   $aImmunization$xComplications
606   $aAutism
615  0$aVaccination$xComplications.
615  0$aImmunization$xComplications.
615  0$aAutism.
676   $a614.47
701   $aStratton$b Kathleen R$01593160
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Promotion and Disease Prevention.
712 02$aInstitute of Medicine (U.S.).$bImmunization Safety Review Committee.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910826813403321
996   $aImmunization safety review$93945068
997   $aUNINA